RALGAPA2

Chr 20

Ral GTPase activating protein catalytic subunit alpha 2

Also known as: AS250, C20orf74, bA287B20.1, dJ1049G11, dJ1049G11.4, p220

Predicted to enable GTPase activator activity and protein heterodimerization activity. Predicted to be involved in activation of GTPase activity. Predicted to act upstream of or within Ral protein signal transduction; regulation of exocyst localization; and regulation of protein localization. Located in cytosol. [provided by Alliance of Genome Resources, Jun 2026]

ResearchGenerating clinical summary…
0
Active trials
2
Pubs (1 yr)
P/LP submissions
P/LP missense
0.59
LOEUF
DN
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.59LOEUF
pLI 0.000
Z-score 4.98
OE 0.46 (0.360.59)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
0.89Z-score
OE missense 0.92 (0.870.97)
877 obs / 954.2 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.46 (0.360.59)
00.351.4
Missense OE?0.92 (0.870.97)
00.61.4
Synonymous OE?1.04
01.21.6
LoF obs/exp: 45 / 98.3Missense obs/exp: 877 / 954.2Syn Z: -0.68

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

RALGAPA2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →